All treatments
Treatment
VIZAMYL 400 MBq/mL solution for injection clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Parallel Group, Randomized, Double-Blind, Placebo-Controlled, 3-Arm, Multicenter Treatment Study to Evaluate the Efficacy and Safety of GSK4527226 [AL101] Intravenous Infusion Compared with Placebo in Patients with Early Alzheimer’s Disease
This study is testing a new medicine called GSK4527226 (also known as AL101) for people in the early stages of Alzheimer's disease. Researchers want to see if it's safe and if it can help improve memory and thinking compared to a dummy treatment.
For: Alzheimer's DiseaseGermany · Netherlands · Finland - Ongoing, recruitingTherapeutic exploratory (Phase II)
Prospective, monocentric, exploratory phase II study for the evaluation of the diagnostic use of the tracer PET (18F) -Flutemetamol (Vizamyl®) in patients with cardiac amyloidosis
This study is looking at a special scan called a PET scan to see how a new tracer (a tiny amount of a radioactive substance) called Vizamyl works. We want to see how much of it is taken up by the heart in people with different types of cardiac amyloidosis.
For: cardiac amyloidosisItaly